Literature DB >> 21811264

Recent advances in materials for extended-release antibiotic delivery system.

Ping Gao1, Xin Nie, Meijuan Zou, Yijie Shi, Gang Cheng.   

Abstract

To maintain antimicrobial activity, frequent administration of conventional formulations of many antibiotics with short half-life is necessary. Otherwise, concentration under MIC occurs frequently in the course of anti-infective treatment, which induces antibiotic resistance. By maintaining a constant plasma drug concentration over MIC for a prolonged period, extended-release dosage forms maximize the therapeutic effect of antibiotics while minimizing antibiotic resistance. Another undoubted advantage of extended-release formulation is improved patient compliance. For better release properties, many materials have been introduced into the matrix and coating extended-release system in the past few years. Materials that have been widely used in industry are hydrophilic matrix materials such as hydroxypropylmethylcellulose. The excellent biocompatibility and extensive laboratory studies provide biodegradable polymers great potential for industrial applications. In addition, it seems like the researches on tailored materials that are obtained by chemical modification of the existing materials or combination of different carriers in physical mixtures have a long way to go. Meanwhile, with the development of polymers and inorganic porous nanocarriers, nanotechnology is applied increasingly for the extended delivery of antibiotics. This review highlights the development of materials used in extended-release formulation and nanoparticles for antibiotic delivery. We also provide an overview of the antibiotic extended-release products that have provided clinical benefit or are undergoing the clinical trial.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21811264     DOI: 10.1038/ja.2011.58

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  45 in total

1.  In-vitro evaluation of a ciprofloxacin and azithromycin sinus stent for Pseudomonas aeruginosa biofilms.

Authors:  Dong-Jin Lim; Daniel Skinner; John Mclemore; Nick Rivers; Jeffrey Brent Elder; Mark Allen; Connor Koch; John West; Shaoyan Zhang; Harrison M Thompson; Justin P McCormick; Jessica W Grayson; Do-Yeon Cho; Bradford A Woodworth
Journal:  Int Forum Allergy Rhinol       Date:  2019-11-06       Impact factor: 3.858

Review 2.  Controlled release drug delivery systems to improve post-operative pharmacotherapy.

Authors:  Prabhat Bhusal; Jeff Harrison; Manisha Sharma; David S Jones; Andrew G Hill; Darren Svirskis
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

Review 3.  Antimicrobial hydrogels: promising materials for medical application.

Authors:  Kerong Yang; Qing Han; Bingpeng Chen; Yuhao Zheng; Kesong Zhang; Qiang Li; Jincheng Wang
Journal:  Int J Nanomedicine       Date:  2018-04-12

Review 4.  Staphylococcal Osteomyelitis: Disease Progression, Treatment Challenges, and Future Directions.

Authors:  Nicola Kavanagh; Emily J Ryan; Amro Widaa; Gillian Sexton; Jerome Fennell; Sadhbh O'Rourke; Kevin C Cahill; Cathal J Kearney; Fergal J O'Brien; Steven W Kerrigan
Journal:  Clin Microbiol Rev       Date:  2018-02-14       Impact factor: 26.132

5.  Tolerance and pharmacokinetics of a ciprofloxacin-coated sinus stent in a preclinical model.

Authors:  Do-Yeon Cho; Kyle Hoffman; Daniel Skinner; Calvin Mackey; Dong Jin Lim; Grant C Alexander; Chae Yun Bae; Dong Keun Han; Ho-Wook Jun; Bradford A Woodworth
Journal:  Int Forum Allergy Rhinol       Date:  2016-12-19       Impact factor: 3.858

6.  Increased cellular uptake of lauryl gallate loaded in superparamagnetic poly(methyl methacrylate) nanoparticles due to surface modification with folic acid.

Authors:  Paulo Emilio Feuser; Juan Marcelo Carpio Arévalo; Enio Lima Junior; Gustavo Rodrigues Rossi; Edvaldo da Silva Trindade; Maria Eliane Merlin Rocha; Amanda Virtuoso Jacques; Eduardo Ricci-Júnior; Maria Claudia Santos-Silva; Claudia Sayer; Pedro H Hermes de Araújo
Journal:  J Mater Sci Mater Med       Date:  2016-10-27       Impact factor: 3.896

Review 7.  Nanoparticle-Based Therapies for Wound Biofilm Infection: Opportunities and Challenges.

Authors:  Min-Ho Kim
Journal:  IEEE Trans Nanobioscience       Date:  2016-03-02       Impact factor: 2.935

8.  In-vitro evaluation of a ciprofloxacin- and ivacaftor-coated sinus stent against Pseudomonas aeruginosa biofilms.

Authors:  Do-Yeon Cho; Dong-Jin Lim; Calvin Mackey; Christopher G Weeks; Jaime A Peña Garcia; Daniel Skinner; Shaoyan Zhang; Justin McCormick; Bradford A Woodworth
Journal:  Int Forum Allergy Rhinol       Date:  2019-01-31       Impact factor: 3.858

9.  Preclinical therapeutic efficacy of the ciprofloxacin-eluting sinus stent for Pseudomonas aeruginosa sinusitis.

Authors:  Do-Yeon Cho; Dong-Jin Lim; Calvin Mackey; Daniel Skinner; Christopher Weeks; Gobind S Gill; Robert W Hergenrother; William E Swords; Bradford A Woodworth
Journal:  Int Forum Allergy Rhinol       Date:  2018-01-15       Impact factor: 3.858

10.  The Efficacy of Tranexamic Acid in the Reduction of Incidence of Dry Socket: An Institutional Double Blind Study.

Authors:  K P Anand; Swadheena Patro; Abhijita Mohapatra; Sumita Mishra
Journal:  J Clin Diagn Res       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.